课题基金 / 基金详情

Role of MicroRNA 451 in the Pathophysiology of Endometriosis

Role of MicroRNA 451 in the Pathophysiology of Endometriosis
MicroRNA 451 在子宫内膜异位症病理生理学中的作用
批准号:
9020102
负责人:
Asgerally T. Fazleabas
金额:
$18.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2016-08-31

项目摘要

项目成果

Asgerally T. Fazleabas的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):子宫内膜异位症,子宫腔外存在子宫内膜腺体和间质,导致慢性盆腔疼痛和不孕。它影响了10%
英文摘要
DESCRIPTION (provided by applicant): Endometriosis, the presence of endometrial glands and stroma outside of the uterine cavity causes chronic pelvic pain and infertility. It affects 10% of women of reproductive age and 35-50% who are infertile. The average for clinical diagnosis takes 8-11 years and the molecular mechanisms associated with the pathophysiology still remains poorly understood. Our laboratory has undertaken pioneering research in the past 12 years during which we have characterized the causative factors and molecular changes that are involved in the early onset of the disease in a baboon model of experimentally induced endometriosis. MicroRNAs (miR), small non-coding RNAs which regulate posttranscriptional gene regulation, have emerged as important regulators that may contribute to pathophysiology of endometriosis. Our preliminary data suggests that induction of endometriosis leads to rapid and significant changes in the expression of several miRs. This application focuses specifically on the biological functions of miR-451 that is highly down regulated following induction of endometriosis. Changes in miR expression were reflected in the corresponding alterations of its target gene, YWHAZ. We hypothesize that these changes contribute to the progression of endometriosis and altered endometrial function. To test this hypothesis in Specific Aim 1 we propose to the determine mechanisms by which YWHAZ forms a complex with beta-catenin to promote cell proliferation and migration and inhibut apoptosis. In Specific Aim 2 we will focus on xenograft experiments in immunocompromised mice and the targeted delivery of miR mimics, inhibitors and siRNA in vivo to test the efficacy of using miR-based therapeutic approaches for endometriosis. These innovative studies will contribute to our understanding of the molecular mechanisms underlying the etiology of endometriosis and functionally link miR expression to target genes that are pathologically relevant.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Macrophage Migration Inhibitory Factor Receptor, CD74, is Overexpressed in Human and Baboon ( Papio Anubis) Endometriotic Lesions and Modulates Endometriotic Epithelial Cell Survival and Interleukin 8 Expression.
巨噬细胞迁移抑制因子受体 CD74 在人和狒狒 (Papio Anubis) 子宫内膜异位病变中过度表达,并调节子宫内膜异位上皮细胞存活和白介素 8 表达。
DOI: 10.1177/1933719118766262
发表时间: 2018
期刊: Reproductive sciences (Thousand Oaks, Calif.)
影响因子: --
作者: [Nothnick,WarrenB, Falcone,Tommaso, Olson,MarkR, Fazleabas,AsgerallyT, Tawfik,OssamaW, Graham,Amanda]
通讯作者: Graham,Amanda
Regulation of Endometriotic Lesion Development by NOTCH1
  • 批准号:
    10605178
  • 项目类别:
  • 资助金额:
    $55.82万
  • 财政年份:
    2021
  • 负责人:
    Asgerally T. Fazleabas
  • 依托单位:
Regulation of Endometriotic Lesion Development by NOTCH1
  • 批准号:
    10379364
  • 项目类别:
  • 资助金额:
    $55.82万
  • 财政年份:
    2021
  • 负责人:
    Asgerally T. Fazleabas
  • 依托单位:
What is Endometriosis? Deep Phenotyping to Advance Diagnosis and Treatment
  • 批准号:
    10398896
  • 项目类别:
  • 资助金额:
    $93.41万
  • 财政年份:
    2018
  • 负责人:
    Asgerally T. Fazleabas
  • 依托单位:
What is Endometriosis? Deep Phenotyping to Advance Diagnosis and Treatment
  • 批准号:
    9916791
  • 项目类别:
  • 资助金额:
    $62.6万
  • 财政年份:
    2018
  • 负责人:
    Asgerally T. Fazleabas
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: